NCT02299102

Brief Summary

This single center study will compare the manual standard bone marrow aspiration device to the powered ported bone marrow aspiration device for use in the iliac crest in healthy adult volunteers. The study will evaluate the subjects' perceived level of pain, time to sample acquisition, and quality of specimen yield of these devices. Each subject will receive bilateral bone marrow aspiration procedures using both the manual standard and powered ported devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Dec 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 24, 2014

Completed
7 days until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
11.5 years until next milestone

Results Posted

Study results publicly available

May 29, 2026

Completed
Last Updated

May 29, 2026

Status Verified

December 1, 2016

Enrollment Period

Same day

First QC Date

November 17, 2014

Results QC Date

April 7, 2026

Last Update Submit

May 4, 2026

Conditions

Keywords

Aspiration ProceduresBone Marrowpowered ported bone marrow aspiration procedures

Outcome Measures

Primary Outcomes (2)

  • Quality of Aspirate Specimen Yield Total Score -Jamshidi Manual Standard Device

    The Quality of Aspirate Specimen Yield Total Score is a sum score using the 3 quality rating scales below. The Score range: 0 to 8; Higher scores mean greater quality. Direct Smears- Cellularity: 0= obviously dilute, no good particles or adequate megakaryocytes (MK) 1. probably slightly dilute, particles and MK present 2. cellular, good particles; MK present on edge, smears reflect clot section cellularity Particle Crush Smears: Evaluate presence of particles and quality of cellularity: 0= no particles 1. few particles; difficult to evaluate marrow cellularity and adequacy of MK 2. good particles; adequate material to evaluate MK 3. many particles, some large, with MK easily evaluated Clot Sections: Evaluate quantity and quality of particles 0= insufficient or no particles for interpretation 1. few small particles; difficult to determine cellularity 2. several particles, good marrow cellularity 3. numerous particles (some large); easy to assess cellularity and cell composition

    analyzed and results received within 30 days of Day 1 procedures

  • Quality of Aspirate Specimen Yield Total Score -OnControl Power Ported Device

    The Quality of Aspirate Specimen Yield Total Score is a sum score using the 3 quality rating scales below. The Score range: 0 to 8; Higher scores mean greater quality. Direct Smears- Cellularity: 0= obviously dilute, no good particles or adequate megakaryocytes (MK) 1. probably slightly dilute, particles and MK present 2. cellular, good particles; MK present on edge, smears reflect clot section cellularity Particle Crush Smears: Evaluate presence of particles and quality of cellularity: 0= no particles 1. few particles; difficult to evaluate marrow cellularity and adequacy of MK 2. good particles; adequate material to evaluate MK 3. many particles, some large, with MK easily evaluated Clot Sections: Evaluate quantity and quality of particles 0= insufficient or no particles for interpretation 1. few small particles; difficult to determine cellularity 2. several particles, good marrow cellularity 3. numerous particles (some large); easy to assess cellularity and cell composition

    analyzed and results received within 30 days of Day 1 procedures

Secondary Outcomes (8)

  • Level of Pain With Needle Insertion- Jamshidi Manual Standard Device

    Day 1 at time of procedure

  • Level of Pain With Needle Insertion- OnControl Power Ported Device

    Day 1 at time of procedure

  • Level of Pain With Aspiration - Jamshidi Manual Standard Device

    1 Day at time of the procedure

  • Level of Pain With Aspiration - OnControl Power Ported Device

    1 Day at time of the procedure

  • Time to Insertion - Jamshidi Manual Standard Device

    1 Day, during procedure

  • +3 more secondary outcomes

Study Arms (2)

Group 1: First Procedure: Jamshidi Manual Standard Device

OTHER

The Jamshidi manual standard device procedure will be performed first. The OnControl Powered Ported device procedure will be performed second.

Device: Jamshidi Manual Standard DeviceDevice: OnControl Powered Ported Device

Group 2: First Procedure OnControl Powered Ported Device

OTHER

The OnControl power ported device procedure will be performed first. The Jamshidi manual standard device procedure will be performed second.

Device: Jamshidi Manual Standard DeviceDevice: OnControl Powered Ported Device

Interventions

Jamshidi Manual Standard Device

Group 1: First Procedure: Jamshidi Manual Standard DeviceGroup 2: First Procedure OnControl Powered Ported Device

OnControl Powered Ported Device

Group 1: First Procedure: Jamshidi Manual Standard DeviceGroup 2: First Procedure OnControl Powered Ported Device

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults 21 years of age and over
  • Able to lay flat in prone position on a table for up to 1 hour
  • Self-reported as healthy, as confirmed by the investigator during the medical history review and physical examination
  • Female subjects with a negative urine pregnancy test at screening visit

You may not qualify if:

  • Reported fever within 7 days of the screening visit
  • Reported active infection within 7 days of the screening visit
  • Fever on day of study procedure
  • Signs/symptoms of active infection on day of study procedure
  • Imprisoned
  • Self identified as pregnant or lactating
  • Cognitively impaired
  • Patients with one or more conditions precluding bone marrow aspiration
  • Excessive tissue and/or absence of adequate anatomical landmarks in target bone
  • Allergy to local anesthetics
  • Unable to lay flat in prone position
  • Prothrombin time and International Normalized Ratio (PT/INR) results outside of normal range on screening lab work and deemed clinically significant by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Therapy and Research LLC.

San Antonio, Texas, 78217, United States

Location

Results Point of Contact

Title
Tatiana Puga
Organization
Teleflex

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Subject were randomized to determine which device procedure was performed first. Subjects randomized to Group 1 received the Jamshidi Manual Standard device procedure first and the OnControl Powered Ported device procedure second. Subjects ranomized to Group 2 received the OnControl Powered Ported device procedure first and the Jamshidi Manual Standard device procedure second.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2014

First Posted

November 24, 2014

Study Start

December 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

May 29, 2026

Results First Posted

May 29, 2026

Record last verified: 2016-12

Locations